Ronald J. Daniels, Director at BridgeBio Pharma, Inc. (BBIO), sold 23,490 shares at $12.73 ($300K) on 2021-12-28, disclosed to the SEC on 2021-12-30.
Open-market sale of $300k BBIO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.73 | 11,745 | $150K | 49.9% |
| 2 | $12.80 | 11,745 | $150K | 50.1% |
| Total | $12.77 avg | 23,490 | $300K | 100% |
| Filing → |
| BBIO | SELL | 2021-12-30 | $150K | — | Filing → |